Eos Energy Enterprises(EOSE) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:30
Eos Energy Enterprises Q4 & FY 2025 Financial Results February 26, 2026 Disclaimer Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding our expected revenue for the fiscal year ended December 31, 2026, our path to profitability and strategic outlook, statements regarding orders backlog, and o ...
CommScope(COMM) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:30
Fourth Quarter and Full Year 2025 Results February 26, 2026 Important information Caution Regarding Forward Looking Statements These forward-looking statements are subject to various risks and uncertainties, many of which are outside our control, including, without limitation, our dependence on customers' capital spending on data, communication and entertainment equipment, which could be negatively impacted by a regional or global economic downturn, among other factors; the potential impact of higher than n ...
Krispy Kreme(DNUT) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:30
Krispy Kreme, Inc. FOURTH QUARTER AND FULL YEAR 2025 EARNINGS PRESENTATION FEBRUARY 26, 2026 KRISPY KREME | 4Q25 EARNINGS 1 Cautionary Note Regarding Forward-Looking Statements Certain statements made in this presentation and on the conference call that this presentation accompanies are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by use of forward-looking terminology, including terms such as "plan," "beli ...
Perrigo(PRGO) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:30
Q4 & FY2025 Earnings Presentation February 26, 2026 Bradley Joseph VP Global Investor Relations 3 Agenda Brad Joseph • Introduction Patrick Lockwood-Taylor Eduardo Bezerra Forward-Looking Statements Certain statements in this presentation are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or our future financial performance and involve known and u ...
Ligand(LGND) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:30
Fourth Quarter and Full Year 2025 Financial Results F E B R U A R Y 2 6 , 2 0 2 6 | FINANCIAL | 48% Full-year royalty revenue growth over 2024 | | --- | --- | | Strong financial performance | 42% Full-year core adjusted EPS growth to $8.131 per share | | BUSINESS DEVELOPMENT | Scaling the BD function to capture value from our deep investment pipeline | | Highly productive, rigorous process | ~$1B Deployable capital (including credit facility) | | | Positions us for continued growth and expansion across our ...
Playtika(PLTK) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:30
February 26, 2026 LEGAL DISCLAIMER Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Section 21E of the Exchange Act. All statements other than statements of historical facts contained in this presentation, including statements regarding our business strategy, plans and our objectives for future operations, are forward-looking statements. Further, statements that include words such as "antici ...
argenx(ARGX) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:30
Certain statements contained in this presentation, other than present and historical facts and conditions independently verifiable at the date hereof, may constitute forward-looking statements. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "advance," "broaden," "build," "deliver," and "expand," and include statements argenx makes regarding its new era of innovation in immunology; its advancement of its Vision 2030, including (1) 5 new molec ...
Montrose Environmental(MEG) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:30
2025 EARNINGS: FULL YEAR and 4Q RESULTS FEBRUARY 26, 2026 © Montrose Environmental Group, Inc. 1 DISCLOSURES SAFE HARBOR Statements contained herein and in the accompanying oral presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may be identified by the use of words such as "intend," "expect", and "may", and other similar expressions that pr ...
Bentley(BSY) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:15
© 2026 Bentley Systems, Incorporated. All rights reserved. 1 February 26, 2026 Perspectives from the Executive Chair 01 Perspectives from the CEO 02 Perspectives from the CFO Q&A 03 04 © 2026 Bentley Systems, Incorporated. All rights reserved. 2 Agenda Disclaimer BSY fourth quarter and full year 2025 results and 2026 financial outlook This presentation includes forward-looking statements regarding the future results of operations and financial position, business strategy, and plans and objectives for future ...
Collegium Pharmaceutical(COLL) - 2025 Q4 - Earnings Call Presentation
2026-02-26 13:00
Q4 and FY2025 Earnings Report February 26, 2026 | Nasdaq: COLL In this presentation, we discuss the following financial measures that are not calculated in accordance with GAAP, to supplement our consolidated financial statements presented on a GAAP basis. Adjusted EBITDA Adjusted EBITDA is a non-GAAP financial measure that represents GAAP net income or loss adjusted to exclude interest expense, interest income, the benefit from or provision for income taxes, depreciation, amortization, stock-based compensa ...